Editorial Expression of Concern: Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function

Affiliations

• ¹ Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy. guido.serini@ircc.it.
• ² Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy.
• ³ Abt. Molekularbiologie Institut für Allgemeine Zoologie und Genetik, Westfälische Wilhelms-Universität, Münster, Germany.
• ⁴ Division of Molecular Oncology, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy.
• ⁵ Division of Developmental Biology, National Institute for Medical Research, London, UK.
• ⁶ Department of Biological Sciences, Howard Hughes Medical Institute, Stanford University, Stanford, California, USA.
• ⁷ Department of Biochemistry and Molecular Biology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
• ⁸ Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy. federico.bussolino@ircc.it.